BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Mnemo Breaks French Series A Record, Targets Greater Tumor Specificity

  The Paris-based biotech will use the funds to create targeted immuno-oncology treatments for a broader range of patients with its next-generation CAR-T and epigenetics platform.

  June 15, 2021

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Revive Therapeutics Advances Repurposed Drug for Mild to Moderate COVID-19

  Repurposed drugs became the front-line defense against COVID-19 within a few months of the pandemic’s emergence. Now bucillamine, currently in Phase III trials in the U.S., may be poised to join them.

  June 15, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Business

  Former FDA Head Takes on Exec Role at Flagship’s Preemptive Health Initiative

  The new division would benefit from Hahn’s experience and help steer the company’s Preemptive Medicine and Health Security initiative.

  June 15, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Pivotal Late-Stage Trial Shows Major Depressive Drug Significantly Reduces Symptoms

  The study drug is a once-daily, two-week therapy developed by Sage Therapeutics and Biogen for major depressive disorder (MDD) and postpartum depression (PPD).

  June 15, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Genetown

  Current COVID-19 Vaccines Prove Efficacy Against Dangerous Delta Variant

  A recent study conducted by Public Health England found that the available vaccines were “highly effective” at preventing hospitalization after two doses.

  June 15, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Discovery of New Childhood Form of ALS Could Inform Future Research

  Besides providing a sense of hope for children with this devastating disease, this research could offer another clue toward unlocking the mystery behind other forms of ALS.

  June 15, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Drug Development

  COVID-19 News: Ocugen Secures Manufacturing, Ampio Stops Study and More

  Please check out the biopharma industry’s COVID-19 stories that are trending for June 15, 2021.

  June 15, 2021

   · 

  3 min read

   · 

  BioSpace Editorial Staff
• 

  BioHarvest Sciences Inc. Reveals VINIA Anti-Aging Capabilities via Blood Flow Improvement

  VINIA(R)'s ability to increase dilation of arteries and to reduce blood vessel constriction allows it to fight the human aging process

  June 15, 2021

   · 

  6 min read
• 

  Key Business Development Skills Every Manager Should Have

  Here are some important business development skills that you can learn for optimum performance. These skills are important as you will be managing the business side.

  June 15, 2021

   · 

  4 min read

   · 

  Lorenzo Soliman
• 

  Drug Development

  Lilly Launches Head-to-Head Trial in Quest to Bolster Migraine Preventive Drug Emgality

  Eli Lilly and Company announced Tuesday the launch of a head-to-head study to compare once-monthly injectable Emgality® (galcanezumab-gnlm) with Nurtec® ODT (rimegepant) for the prevention of migraine.

  June 15, 2021

   · 

  2 min read

   · 

  Brandon May